Factor VIII Binding Assay of von Willebrand Factor and the Diagnosis of Type 2N von Willebrand Disease -Results of an International Survey

• References

• 1 Mazurier C, Jorieux S, Dieval J. Evidence for an abnormal FVIII/von Willebrand factor interaction in a patient presenting as a lifelong bleeding diathesis associated with FVIII deficiency. Thromb Haemost 1989; 62: 472 (Abstr. 1479).
• 2 Nishino M, Girma JP, Rothschild C, Fressinaud F, Meyer D. A new variant of von Willebrand disease with defective binding to factor VIII. Thromb Haemost 1989; 62: 472 (Abstr. 1477).
• 3 Nishino M, Girma JP, Rothschild C, Fressinaud E, Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood 1989; 74: 1591-1599
• 4 Mazurier C, Dieval J, Jorieux S, Delobel J, Goudemand M. A new von Willebrand factor (vWF) defect in a patient with factor VIII deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 1990; 75: 20-26
• 5 Gaucher C, Jorieux S, Mercier B, Oufkir D, Mazurier C. The “Normandy” variant of von Willebrand’s disease: characterization of a point mutation in the von Willebrand factor gene. Blood 1991; 77: 1937-1941
• 6 Tuley EA, Gaucher C, Jorieux S, Worrall NK, Sadler E, Mazurier C. Expression of von Willebrand factor “Normandy”: an autosomal mutation that mimics hemophilia A. Proc Natl Acad Sci USA 1991; 88: 6377-6381
• 7 Cacheris PM, Nichols WC, Ginsburg D. Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction:. J Biol Chem 1991; 266: 13499-13502
• 8 Kroner PA, Friedman KD, Fahs S, Scott JP, Montgomery RR. Abnormal binding of factor VIII is linked with the substitution of Glutamine for Arginine 91 in von Willebrand factor in a variant form of von Willebrand disease. J Biol Chem 1991; 266: 19146-19149
• 9 Jorieux S, Tuley EA, Gaucher C, Mazurier C, Sadler JE. The mutation Arg (53)→Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor. Blood 1992; 79: 563-567
• 10 Gaucher C, Mercier B, Jorieux S, Oufkir D, Mazurier C. Identification of two point mutations in the von Willebrand factor gene of three families with the “Normandy” variant of von Willebrand disease. Br J Haematol 1991; 78: 506-514
• 11 Peerlinck K, Eikenboom JC, Ploos van Amstel HK, Sangtawesin W, Amout J, Reitsma PH, Vermylen J, Briet E. A patient with von Willebrand’s disease characterized by a coumpound heterozygosity for a substitution of Arg 854 by Gin in the putative factor VUI-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele. Br J Haematol 1992; 80: 358-363
• 12 Eikenboom JCJ, Reitsma PH, Peerlinck KMJ, Briet E. Recessive inheritance of von Willebrand’s disease type 1. Lancet 1993; 341: 982-986
• 13 Nishino M, Miura S, Yoshioka A, Kuwahara I, Nishimura T, Hamada K, Fukui H. Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan. Int J Hematol 1993; 57: 163-173
• 14 Wise RJ, Ewenstein BM, Gorlin J, Narins SC, Jesson M, Handin RI. Autosomal recessive transmission of hemophilia a due to a von Willebrand factor mutation. Hum Genet 1993; 91: 367-372
• 15 Siguret V, Lavergne JM, Cherel G, Boyer-Neumann C, Ribba AS, Bahnak BR, Meyer D, Pietu G. Novel case of compound heterozygosity with Normandy/Type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression of the mRNA level causing type I vWD. Hum Genet 1994; 93: 95-102
• 16 Perez-Casal M, Daly M, Peake I. A case of recessive type 2N von Wille-brand’s disease due to Arg53Trp substitution. Am J Hemat 1995; 48: 140
• 17 Lavergne JM, Piao Y, Ribba AS, Girma JP, Siguret V, Pietu G, Boyer-Neumann C, Schandelong A, Bahnak BR, Meyer D. Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression. Thromb Haemost 1993; 70: 691-696
• 18 Mazurier C, Gaucher C, Jorieux S, Parquet-Gemez A, Goudemand M. Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling. Br J Haematol 1990; 76: 372-379
• 19 Lopez-Femandez MF, Blanco-Lopez MJ, Castineira MP, Batlle J. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII. Am J Hematol 1992; 40: 20-27
• 20 Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-525
• 21 Mazurier C. Von Willebrand disease masquerading as haemophilia A. Thromb Haemost 1992; 67: 391-396
• 22 Zhang ZP, Falk G, Blomback M, Egberg N, Anvret M. A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patients. Hum Mol Gen 1992; 1: 767-768
• 23 Kroner PA, Foster PA, Fahs SA, Montgomery RR. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg 19 and His54 in mature von Willebrand factor. Blood 1996; 87: 1013-1021